TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.270
-0.110 (-7.97%)
Apr 1, 2025, 4:00 PM EDT - Market closed

TScan Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
178.69133.36120.03161.4134.79
Upgrade
Short-Term Investments
111.4258.69---
Upgrade
Cash & Short-Term Investments
290.11192.04120.03161.4134.79
Upgrade
Cash Growth
51.06%60.00%-25.64%363.93%-16.70%
Upgrade
Prepaid Expenses
2.612.194.14.251.65
Upgrade
Total Current Assets
292.72194.24124.13165.6536.45
Upgrade
Property, Plant & Equipment
71.671.2369.217.2612.53
Upgrade
Other Long-Term Assets
6.86.685.765.20.76
Upgrade
Total Assets
371.12272.15199.09188.1149.74
Upgrade
Accounts Payable
4.282.372.911.772.91
Upgrade
Accrued Expenses
15.3310.296.415.512.36
Upgrade
Current Portion of Long-Term Debt
-3.35---
Upgrade
Current Portion of Leases
4.573.253.681.651.42
Upgrade
Current Unearned Revenue
11.710.143.8711.4110.63
Upgrade
Other Current Liabilities
0.080.430.431.010.13
Upgrade
Total Current Liabilities
35.9629.8217.3121.3417.45
Upgrade
Long-Term Debt
32.0726.729.29--
Upgrade
Long-Term Leases
60.7459.1453.014.396.02
Upgrade
Long-Term Unearned Revenue
1.255.62-1.58.82
Upgrade
Other Long-Term Liabilities
0.14-0.050.10.24
Upgrade
Total Liabilities
130.15121.2899.6627.3332.52
Upgrade
Common Stock
0.010.01000
Upgrade
Additional Paid-In Capital
616.01398.46257.81252.931.07
Upgrade
Retained Earnings
-375.1-247.6-158.38-92.16-43.53
Upgrade
Comprehensive Income & Other
0.05----
Upgrade
Total Common Equity
240.97150.8799.43160.78-42.46
Upgrade
Shareholders' Equity
240.97150.8799.43160.7817.22
Upgrade
Total Liabilities & Equity
371.12272.15199.09188.1149.74
Upgrade
Total Debt
97.3892.4385.986.047.43
Upgrade
Net Cash (Debt)
192.7399.6134.04155.3627.36
Upgrade
Net Cash Growth
93.48%192.60%-78.09%467.91%-25.82%
Upgrade
Net Cash Per Share
3.412.081.4213.3229.87
Upgrade
Filing Date Shares Outstanding
56.5947.8824.2323.861.14
Upgrade
Total Common Shares Outstanding
56.5947.8324.2323.911.14
Upgrade
Working Capital
256.77164.42106.82144.3119
Upgrade
Book Value Per Share
4.263.154.106.72-37.38
Upgrade
Tangible Book Value
240.97150.8799.43160.78-42.46
Upgrade
Tangible Book Value Per Share
4.263.154.106.72-37.38
Upgrade
Machinery
22.5918.6316.8712.156.14
Upgrade
Construction In Progress
0.10.550.011.260.78
Upgrade
Leasehold Improvements
3.263.163.453.430.49
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q